1. Home
  2. CHCO vs OGN Comparison

CHCO vs OGN Comparison

Compare CHCO & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo City Holding Company

CHCO

City Holding Company

HOLD

Current Price

$119.53

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.29

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCO
OGN
Founded
1957
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CHCO
OGN
Price
$119.53
$7.29
Analyst Decision
Hold
Hold
Analyst Count
3
5
Target Price
$128.33
$14.10
AVG Volume (30 Days)
103.9K
4.5M
Earning Date
01-22-2026
02-12-2026
Dividend Yield
2.92%
1.12%
EPS Growth
11.27
N/A
EPS
8.68
1.91
Revenue
$307,880,000.00
$6,301,000,000.00
Revenue This Year
$10.45
N/A
Revenue Next Year
$3.18
N/A
P/E Ratio
$13.74
$3.75
Revenue Growth
6.33
N/A
52 Week Low
$102.22
$6.18
52 Week High
$133.59
$17.23

Technical Indicators

Market Signals
Indicator
CHCO
OGN
Relative Strength Index (RSI) 36.12 51.62
Support Level $118.43 $7.08
Resistance Level $124.43 $7.21
Average True Range (ATR) 2.50 0.20
MACD -0.73 0.05
Stochastic Oscillator 9.20 83.44

Price Performance

Historical Comparison
CHCO
OGN

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: